Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways
Author:
Open Access
- 1 January 2013
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Orthopedics
- Vol. 4 (1) , 1-6
Abstract
Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathwaysKeywords
This publication has 46 references indexed in Scilit:
- The Pathogenesis of Rheumatoid ArthritisNew England Journal of Medicine, 2011
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsAnnals of the Rheumatic Diseases, 2010
- Promising bone-related therapeutic targets for rheumatoid arthritisNature Reviews Rheumatology, 2009
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Bone mineral density in patients with recently diagnosed, active rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Cyclosporin and methotrexate therapyAnnals of the Rheumatic Diseases, 2003
- Evolving concepts of rheumatoid arthritisNature, 2003
- Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2000
- A New Mechanism of Bone Destruction in Rheumatoid Arthritis: Synovial Fibroblasts Induce OsteoclastogenesisBiochemical and Biophysical Research Communications, 1997
- Biannual Radiographic Assessments of Hands and Feet in a Three‐Year Prospective Followup of Patients with Early Rheumatoid ArthritisArthritis & Rheumatism, 1992